Traditional DNA synthesis methods struggle with scalability and accuracy when generating long DNA fragments, hindering advancements in various biotechnological applications. These limitations pose challenges in producing high-quality DNA sequences efficiently.

Meiyou Technology is developing an enzymatic DNA synthesis and splicing technology designed to produce long, high-quality DNA sequences with improved efficiency. This approach aims to overcome the limitations of existing chemical synthesis methods, which often encounter difficulties in generating long and complex DNA molecules. By leveraging enzymatic reactions, the technology seeks to enhance the accuracy and scalability of DNA synthesis, enabling the production of longer and more intricate DNA constructs. The resulting DNA fragments can then be used in a variety of applications, including gene synthesis, genome editing, and the development of novel biopharmaceuticals.

Enzymatic DNA synthesis for improved accuracy and scalability

DNA splicing technology for assembling long DNA fragments

Production of high-quality DNA sequences

The primary target audience includes researchers, biotechnology companies, and pharmaceutical firms involved in gene synthesis, genome editing, and biopharmaceutical development.